PL EN
  1. www.sciencepharma.pl
  2. Aktualności
  3. URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of April 8, 2015 concerning a additional measures taken to minimize the risk of osteonecrosis of the jaw caused by medicines contain

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of April 8, 2015 concerning a additional measures taken to minimize the risk of osteonecrosis of the jaw caused by medicines contain

16.04.2015
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of April 8, 2015 concerning a additional measures taken to minimize the risk of osteonecrosis of the jaw caused by medicines containing bisphosphonates.
Źródło wiadomośći: http://www.urpl.gov.pl/aktualnosci/informacja-z-dnia-08-04-2015-r-w-sprawie-dodatkowych-dzialan-podjetych-w-celu-zminimalizowania-ryzyka-martwicy-zuchwy-spowodowanej-lekami-zawierajacym

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny